Evotec AG (NASDAQ:EVO – Get Free Report) shares saw unusually-high trading volume on Wednesday . Berenberg Bank cut Evotec from a “buy” rating to a “hold” rating in a research report on Thursday, July 16th. TD Cowen lowered Evotec from a “buy” rating to a “hold” rating and set a $2.00 target price on the stock. Jane Street Group LLC purchased a new position in shares of Evotec in the 4th quarter valued at about $565,000. Evotec Company Profile(Get Free Report)Evotec SE (NASDAQ:EVO) is a global biotechnology company headquartered in Hamburg, Germany, specializing in drug discovery and development partnerships.